Shatavari: uses, studies, potential benefits, and precautions

Article written by the Ômara team · Last updated: August 2026 · Scientific sources consulted up to August 8, 2026

Shatavari (Asparagus racemosus) is a plant whose root holds a major place in Ayurvedic tradition. Often presented as "the women's plant," it is now available in powder or extract form, alone or combined with other ingredients.

However, its reputation exceeds the actual level of available evidence. Several clinical trials published between 2024 and 2026 have studied specific Shatavari root extracts, primarily during perimenopause and menopause. Some results are encouraging, but studies remain heterogeneous, often short, and sometimes funded by the manufacturers of the tested extracts.

To understand what can reasonably be expected from Shatavari, it is therefore necessary to distinguish three things: its traditional uses, the results observed in human trials, and the benefits that still need to be demonstrated.

What is Shatavari?

Shatavari is a climbing plant native to the Indian subcontinent and other regions of Asia. Its botanical name is Asparagus racemosus. It belongs to the same botanical family as common asparagus, although its appearance and use are different.

The most commonly used part is its tuberous root. It can be dried and then ground into powder, or used to produce more concentrated extracts. This distinction is important: a root powder, a concentrated extract, and a standardized extract do not necessarily have the same composition.

The Sanskrit term Shatavari is often translated as "she who possesses a hundred husbands." This traditional expression illustrates the plant's historical association with femininity, fertility, and reproductive vitality. However, it does not constitute clinical proof of action on fertility or hormones.

What is Shatavari's place in Ayurveda?

In Ayurvedic tradition, Shatavari is classified among the rasayana. This term refers to a set of plants and preparations traditionally associated with maintaining vitality and supporting the body over time.

Ayurvedic texts and practitioners generally describe its root as:

• sweet and bitter in taste;
• nourishing and unctuous in qualities;
• cooling by its traditional energy;
• primarily associated with Vata and Pitta profiles.

These concepts belong to Ayurveda's own system of understanding. They should not be automatically translated into modern medical indications. Saying that a plant "calms Pitta," for example, does not prove that it treats hot flashes, inflammation, or a hormonal disorder.

What does Shatavari root contain?

The root of Asparagus racemosus contains several families of plant compounds:

• steroidal saponins, including shatavarins;
• flavonoids and other phenolic compounds;
• mucilage;
• various constituents present in variable proportions depending on the plant, harvest, and extraction method.

Shatavarins are often used as standardization markers. However, their presence alone is not enough to predict the effect of a product. To compare two extracts, it is also necessary to know the part of the plant used, the quantity consumed, the extraction ratio, the standardized percentage, the analysis method, and the controls performed on contaminants.

An extract standardized to 5% shatavarins, an extract advertised as more than 10% shatavarins, and a simple root powder are therefore not interchangeable.

What do human studies on Shatavari really show?

Clinical research on Shatavari has developed rapidly since 2024. This progress is interesting, but it requires careful reading: trials use different proprietary extracts, doses ranging from 100 to 500 mg per day, and populations that do not always correspond to the same stage of menopausal transition.

Perimenopause and menopause: encouraging signals, not universal proof

Taken together, these trials suggest that certain standardized extracts of Shatavari may improve scores related to perimenopause or menopause symptoms. Several studies have notably observed differences on questionnaires such as the Menopause Rating Scale (MRS), the Menopause-Specific Quality of Life (MENQOL), or the Perceived Stress Scale (PSS).

However, it would be excessive to conclude that any Shatavari reduces hot flashes, corrects a hormonal imbalance, or replaces menopause management. The trials do not all test the same preparation, some results are not consistent, and the majority of follow-ups last only eight weeks.

Female sexual well-being: a recent avenue

The trial published in 2026 on 135 women used several validated questionnaires. After eight weeks, the group receiving only Shatavari showed favorable differences in the overall sexual function score, satisfaction, and sexual distress compared to placebo. Other sub-domains evolved mainly in the group combining Shatavari and Ashwagandha.

These results deserve further study, but they do not allow Shatavari to be presented as a treatment for decreased libido, intimate dryness, or a sexual disorder. The measurements largely relied on questionnaires and the study still needs to be replicated by independent teams.

Breastfeeding: a traditional use that requires caution

Shatavari has a long history of use as a galactagogue in Ayurvedic tradition. A smaller, older trial studied prolactin in breastfeeding mothers, but these data are not sufficient to establish a general recommendation.

Breastfeeding is a particular period: the product used, the dose, the mother's health, the infant's health, and other ingredients in a formula must be taken into account. Professional advice is therefore preferable before any supplementation, and this caution is reinforced when a product combines Shatavari with Shilajit.

The most important point: results are not automatically transferable from one extract to another

A study on 300 mg of a 13:1 extract standardized to more than 10% shatavarins does not demonstrate the efficacy of a powder, an unstandardized extract, or a combined formula. The dose in milligrams is not sufficient: the actual concentration and composition of the extract must be known.

This distinction is essential for honestly interpreting research and avoiding turning a study on a proprietary ingredient into a promise applicable to all products on the market.

What Shatavari benefits remain insufficiently demonstrated?

Human data available in August 2026 do not allow us to affirm that Shatavari:

• regulates the menstrual cycle;
• generally "balances hormones";
• increases fertility;
• treats premenstrual syndrome;
• prevents or treats a gynecological condition;
• acts as a treatment for anxiety, insomnia, or depression;
• strengthens immunity;
• improves digestion;
• has a clinically established anti-inflammatory effect for the general public.

Some of these uses come from tradition, animal studies, cell experiments, or exploratory human trials. They may constitute research avenues, but not confirmed clinical benefits.

Powder, extract, or standardized extract: what are the differences?

Root powder

Powder contains dried and ground root. It is closer to traditional use, but its compound content naturally varies depending on origin, harvest, storage, and batch.

Concentrated extract

An extract is obtained by separating and concentrating a portion of the root's constituents. To evaluate it, its extraction ratio must be known. A 10:1 ratio, for example, means that ten units of plant were used to produce one unit of extract, without, however, indicating the shatavarin content.

Standardized extract

A standardized extract guarantees a defined content of one or more markers, such as shatavarins or total saponins. This standardization improves consistency between batches, but does not automatically mean that the product is clinically validated.

How to recognize properly documented Shatavari?

A transparent presentation should specify:

1. the full botanical name: Asparagus racemosus;
2. the part of the plant used, ideally the root;
3. the quantity per capsule and per daily dose;
4. the extraction ratio, when it is an extract;
5. the marker and standardization rate, if they exist;
6. other ingredients and excipients in the formula;
7. microbiological analyses and controls for heavy metals, pesticides, and other contaminants;
8. the batch number and access to the corresponding certificate.

Terms like "premium," "powerful," or "concentrated" do not replace this information.

How to take Shatavari?

There is no universal dosage applicable to all powders and extracts. The trials presented above used different preparations, at doses between 100 and 500 mg per day. Therefore, copying the dosage from a study without having the same extract is not relevant.

In practice, it is advisable to:

• follow the dose indicated on the product;
• not combine several supplements that already contain Shatavari;
• check the complete composition of combined formulas;
• seek advice in case of ongoing treatment, chronic illness, or specific situation;
• discontinue use and seek advice in case of an unusual reaction.

The duration of a clinical trial does not correspond to a guaranteed time frame before experiencing an effect. Schedules promising improvement after 7, 10, or 30 days are not sufficiently substantiated. Recent major trials lasted from 8 to 24 weeks, but this does not predict individual response or the safety of prolonged use.

Precautions, contraindications, and side effects

Recent trials mainly reported mild side effects, including nausea, looser stools, bloating, headaches, or dizziness. Their low frequency in small trials does not rule out rarer reactions.

Professional advice is particularly recommended in the following situations:

• pregnancy, breastfeeding, or planning a pregnancy;
• hormonal treatment, hormonal contraception, or fertility treatment;
• history of or hormone-dependent pathology;
• chronic illness;
• regular medication intake;
• known allergy to asparagus or other plants of the Asparagaceae family;
• onset of a digestive, skin, or unusual reaction after intake.

Estrogenic-like activity is suggested for some compounds or extracts, but its clinical significance remains imperfectly understood. Interactions with contraceptives and hormonal treatments are not sufficiently documented to conclude their presence or absence. Caution is therefore preferable.

Why combine Shatavari with Shilajit?

In Ayurvedic tradition, Shilajit is sometimes described as a yogavahi, meaning a substance traditionally associated with other ingredients in a formula.

The Ômara formula provides, for two capsules:

• 800 mg of concentrated Shatavari root extract;
• 200 mg of Shilajit standardized to 70% fulvic acid.

To date, no published clinical trial has evaluated this specific combination, at this dosage, and with these two ingredients. Therefore, it should not be stated that Shilajit amplifies the effect of Shatavari, increases the absorption of its shatavarins, or strengthens its results in humans.

The combination can be presented as a formulation choice inspired by Ayurvedic tradition. Its evaluation must be based on the composition, traceability, analyses, and precautions specific to each of the two ingredients, and not on a clinical synergy already demonstrated.

Frequently asked questions about Shatavari

What are the benefits of Shatavari?

The most recent human research focuses mainly on certain symptoms and quality of life scores during perimenopause or menopause, as well as on some aspects of female sexual well-being. The results are encouraging for specific extracts, but do not confirm all the benefits generally attributed to Shatavari.

Is Shatavari only for women?

No. Its traditional history and the majority of recent studies mainly concern women's health, but the plant is not botanically exclusive to women. Its benefits in men are much less studied.

Is Shatavari a phytoestrogen?

Estrogenic-like activity has been proposed for some compounds and extracts. However, the mechanism and its clinical scope are not fully established. Shatavari should not be presented as a source of estrogens or a demonstrated hormonal regulator.

Can Shatavari be taken during menopause?

Several recent trials have focused on perimenopausal, menopausal, or postmenopausal women. This does not mean that Shatavari is suitable for all situations. Significant, unusual, or persistent symptoms require professional evaluation.

Can Shatavari be taken with birth control pills or hormone therapy?

Interactions with contraceptives and hormonal treatments are not sufficiently studied. It is best to seek advice from a healthcare professional before combining them.

Does Shatavari improve fertility?

Shatavari is traditionally associated with fertility, but human clinical data remains insufficient to confirm this effect. It should not delay a medical check-up in case of difficulty conceiving.

Does Shatavari help with premenstrual syndrome?

This use is often mentioned, but human trials specifically dedicated to premenstrual syndrome are insufficient. Therefore, it is not possible to promise an effect on PMS or cycle regularity.

What are the dangers or possible side effects?

Short-term trials mainly reported mild effects, including nausea, looser stools, bloating, headaches, or dizziness. Long-term safety and drug interactions remain less well documented.

What is the difference between Shatavari powder and extract?

Powder contains the entire dried and ground root. An extract concentrates a part of its constituents. To compare two extracts, one must look at the extraction ratio, the daily quantity, and the possible standardization in shatavarins or saponins.

How long does it take to feel an effect?

There is no reliable timeframe. Recent major trials lasted between 8 and 24 weeks, but their duration does not constitute a promise of individual results. A precise timeline of effects cannot be established from current data.

Can Shatavari and Shilajit be combined?

The combination exists in formulas inspired by Ayurveda. However, no clinical trial has demonstrated a specific effect of the Shatavari–Shilajit duo. It is essential to check the composition, quantities, quality, and specific precautions for each ingredient.

In summary

Shatavari is an important root in Ayurvedic tradition, and clinical research has significantly progressed since 2024. Several controlled trials have observed favorable results with standardized extracts in certain contexts related to perimenopause, menopause, and female well-being.

However, these works are not sufficient to validate all the promises associated with the plant. Studies often remain short, use different extracts, and are sometimes funded by the manufacturers of the evaluated ingredients. The results of a proprietary extract cannot be automatically applied to a powder, an unstandardized extract, or a combined formula.

A serious approach therefore consists of clearly separating tradition and clinical evidence, examining the form used, the dosage, the extraction ratio, standardization, analyses, and precautions, and then seeking advice when a medical situation or treatment requires it.

To place Shatavari among other plants in this family, also consult our guide to adaptogenic plants.

Scientific References

1. Alok S, Jain SK, Verma A, et al. Plant profile, phytochemistry and pharmacology of Asparagus racemosus (Shatavari): a review. Asian Pacific Journal of Tropical Disease. 2013;3(3):242–251. View publication.
2. Gudise VS, Dasari MP, Kuricheti SSK. Efficacy and Safety of Shatavari Root Extract for the Management of Menopausal Symptoms: A Double-Blind, Multicenter, Randomized Controlled Trial. Cureus. 2024;16(4):e57879. View publication.
3. Pingali U, Nutalapati C, Wang Y. Ashwagandha and Shatavari Extracts Dose-Dependently Reduce Menopause Symptoms, Vascular Dysfunction, and Bone Resorption in Postmenopausal Women: A Randomized, Double-Blind, Placebo-Controlled Study. Journal of Menopausal Medicine. 2025;31(1):21–34. View publication.
4. Mahajan S, Avad P, Langade J. Efficacy and Safety of Shatavari (Asparagus racemosus) Root Extract for Perimenopause: Randomized, Double-Blind, Placebo-Controlled Study. International Journal of Women’s Health. 2025;17:4057–4073. View publication.
5. Ademola J, Ajgaonkar A, Debnath T, et al. Efficacy and safety of Shatavari root extract for menopausal symptoms: a randomized, double-blind, three-arm, placebo-controlled study. Frontiers in Reproductive Health. 2025;7:1654503. View publication.
6. Ademola J, Mahajan S, Srivathsan M, Langade D. Effects of Shatavari Root Extract on Sexual Wellness in Women. International Journal of Women’s Health. 2026;18. View publication.
7. Chattopadhyay R, Karmakar S, Chakraborty TR, et al. SheVari4®, a proprietary root extract from Asparagus racemosus, ameliorates menopausal health. Food & Nutrition Research. 2026;70. View publication.
8. Gupta M, Shaw B. A Double-Blind Randomized Clinical Trial for Evaluation of Galactogogue Activity of Asparagus racemosus Willd. Iranian Journal of Pharmaceutical Research. 2011;10(1):167–172. View publication.

This content is provided for informational purposes only. It does not replace diagnosis, treatment, or the advice of a healthcare professional. A dietary supplement is not a substitute for a varied and balanced diet or a healthy lifestyle.